Skip to main content
Erschienen in: Herz 2/2012

01.03.2012 | Review article

Causes of moderate to large pericardial effusion requiring pericardiocentesis in 140 Han Chinese patients

verfasst von: W. Ma, J. Liu, Y. Zeng, S. Chen, Y. Zheng, S. Ye, L. Lan, Q. Liu, H.-J. Weig, Q. Liu, MD, PhD

Erschienen in: Herz | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Causes of pericardial effusion requiring pericardiocentesis are very complex; a summary of 140 patients, especially those having iatrogenic pericardial effusion, is rare.

Methods

We prospectively analyzed the clinical data and etiology of moderate to large pericardial effusion requiring pericardiocentesis and drainage in 140 consecutive Han Chinese patients from January 2007 to December 2009.

Results

Pericardiocentesis was successfully performed and effective in all patients. There were 9 cases with transudates, while the remaining 131 cases were diagnosed with exudates (neoplastic in 54 patients, tuberculous in 40 patients, 9 cases of connective tissue diseases, 12 cases undergoing cardiac catheterization, and 8 cases of acute myocardial infarction). Among the 54 malignancies, 30 patients had lung cancer, 7 had breast cancer, and 4 had liver cancer. No differences in the clinical characteristics and the results of routine and biochemistry studies in the pericardial fluid between tuberculous and malignant groups were found. Of the 12 patients undergoing cardiac catheterization, 6 cases had undergone catheter ablation for tachycardia and 4 cases had undergone percutaneous coronary intervention. The 6 patients undergoing catheter ablation were women and the ratio of pericardial effusion was higher in women (6/436) than in men (0/462; p<0.05). Pericardiocentesis and drainage was effective in the 6 patients who underwent catheter ablation, and the remaining 6 patients underwent surgical intervention after pericardiocentesis and drainage. All 8 patients with acute myocardial infarction died during hospitalization.

Conclusion

In China, most moderate to large pericardial effusions requiring pericardiocentesis and drainage were exudates and bloody, which were mainly caused by malignancy and tuberculosis. However, the incidence of iatrogenic pericardial effusion has been increasing and should not be ignored. Pericardiocentesis and drainage were effective.
Literatur
1.
Zurück zum Zitat Mookadam F, Jiamsripong P, Oh JK, Khandheria BK (2009) Spectrum of pericardial disease: part I. Expert Rev Cardiovasc Ther 7(9):1149–1157PubMedCrossRef Mookadam F, Jiamsripong P, Oh JK, Khandheria BK (2009) Spectrum of pericardial disease: part I. Expert Rev Cardiovasc Ther 7(9):1149–1157PubMedCrossRef
2.
Zurück zum Zitat Jiamsripong P, Mookadam F, Oh JK, Khandheria BK (2009) Spectrum of pericardial disease: part II. Expert Rev Cardiovasc Ther 7(9):1159–1169PubMedCrossRef Jiamsripong P, Mookadam F, Oh JK, Khandheria BK (2009) Spectrum of pericardial disease: part II. Expert Rev Cardiovasc Ther 7(9):1159–1169PubMedCrossRef
3.
Zurück zum Zitat Mayosi BM, Burgess LJ, Doubell AF (2005) Tuberculous pericarditis. Circulation 112(23):3608–3616PubMedCrossRef Mayosi BM, Burgess LJ, Doubell AF (2005) Tuberculous pericarditis. Circulation 112(23):3608–3616PubMedCrossRef
5.
Zurück zum Zitat Kil UH, Jung HO, Koh YS et al (2008) Prognosis of large, symptomatic pericardial effusion treated by echo-guided percutaneous pericardiocentesis. Clin Cardiol 31(11):531–537PubMedCrossRef Kil UH, Jung HO, Koh YS et al (2008) Prognosis of large, symptomatic pericardial effusion treated by echo-guided percutaneous pericardiocentesis. Clin Cardiol 31(11):531–537PubMedCrossRef
6.
Zurück zum Zitat Seferović PM, Ristić AD, Imazio M et al (2006) Management strategies in pericardial emergencies. Herz 31(9):891–900PubMedCrossRef Seferović PM, Ristić AD, Imazio M et al (2006) Management strategies in pericardial emergencies. Herz 31(9):891–900PubMedCrossRef
7.
Zurück zum Zitat Sagristà-Sauleda J, Mercé J, Permanyer-Miralda G, Soler-Soler J (2000) Clinical clues to the causes of large pericardial effusion. Am J Med 109(2):95–101PubMedCrossRef Sagristà-Sauleda J, Mercé J, Permanyer-Miralda G, Soler-Soler J (2000) Clinical clues to the causes of large pericardial effusion. Am J Med 109(2):95–101PubMedCrossRef
8.
Zurück zum Zitat Imazio M, Brucato A, Derosa FG et al (2009) Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med (Hagerstown) 10(3):217–230CrossRef Imazio M, Brucato A, Derosa FG et al (2009) Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med (Hagerstown) 10(3):217–230CrossRef
9.
Zurück zum Zitat Erbel R, Lind A, Plato C et al (2004) Davos lecture 2004: pericarditis constrictiva with severe pericardial effusion diagnosed with significant therapeutic consequences. Herz 29(5):563–567PubMed Erbel R, Lind A, Plato C et al (2004) Davos lecture 2004: pericarditis constrictiva with severe pericardial effusion diagnosed with significant therapeutic consequences. Herz 29(5):563–567PubMed
10.
Zurück zum Zitat Zhang LH, Ni C, Guo LL (2008) Clinical and pathological characteristics of constrictive pericarditis in China. Zhonghua Xin Xue Guan Bing Za Zhi 36(9):812–815 [Article in Chinese]PubMed Zhang LH, Ni C, Guo LL (2008) Clinical and pathological characteristics of constrictive pericarditis in China. Zhonghua Xin Xue Guan Bing Za Zhi 36(9):812–815 [Article in Chinese]PubMed
11.
Zurück zum Zitat Ben-Horin S, Bank I, Shinfeld A et al (2007) Diagnostic value of the biochemical composition of pericardial effusion in patients undergoing pericardiocentesis. Am J Cardiol 99(9):1294–1297PubMedCrossRef Ben-Horin S, Bank I, Shinfeld A et al (2007) Diagnostic value of the biochemical composition of pericardial effusion in patients undergoing pericardiocentesis. Am J Cardiol 99(9):1294–1297PubMedCrossRef
12.
Zurück zum Zitat Cabrerizo JL, Zalba B, Ridruejo R (2009) Cardiac tamponade for massive pericardial effusion secondary to primary hypothyroidism. Med Intensiva 33(3):151PubMedCrossRef Cabrerizo JL, Zalba B, Ridruejo R (2009) Cardiac tamponade for massive pericardial effusion secondary to primary hypothyroidism. Med Intensiva 33(3):151PubMedCrossRef
13.
Zurück zum Zitat Maisch B, Seferović PM, Ristić AD et al (2004) Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 25(7):587–610PubMedCrossRef Maisch B, Seferović PM, Ristić AD et al (2004) Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 25(7):587–610PubMedCrossRef
14.
Zurück zum Zitat Imazio M, Brucato A, Trinchero R, Adler Y (2009) Diagnosis and management of pericardial diseases. Nat Rev Cardiol 6(12):743–751PubMedCrossRef Imazio M, Brucato A, Trinchero R, Adler Y (2009) Diagnosis and management of pericardial diseases. Nat Rev Cardiol 6(12):743–751PubMedCrossRef
15.
Zurück zum Zitat Karatolios K, Alter P, Maisch B (2009) Differentiation of malignant from nonmalignant, inflammatory pericardial effusions with biomarkers. Herz 34(8):624–633PubMedCrossRef Karatolios K, Alter P, Maisch B (2009) Differentiation of malignant from nonmalignant, inflammatory pericardial effusions with biomarkers. Herz 34(8):624–633PubMedCrossRef
16.
Zurück zum Zitat Liu J, Zeng Y, Ma W et al (2010) Preliminary investigation of the clinical value of vascular endothelial growth factor and hypoxia-inducible factor-1alpha in pericardial fluid in diagnosing malignant and tuberculous pericardial effusion. Cardiology 116(1):37–41PubMedCrossRef Liu J, Zeng Y, Ma W et al (2010) Preliminary investigation of the clinical value of vascular endothelial growth factor and hypoxia-inducible factor-1alpha in pericardial fluid in diagnosing malignant and tuberculous pericardial effusion. Cardiology 116(1):37–41PubMedCrossRef
17.
Zurück zum Zitat Kabukcu M, Demircioglu F, Yanik E et al (2004) Pericardial tamponade and large pericardial effusions: causal factors and efficacy of percutaneous catheter drainage in 50 patients. Tex Heart Inst J 31(4):398–403PubMed Kabukcu M, Demircioglu F, Yanik E et al (2004) Pericardial tamponade and large pericardial effusions: causal factors and efficacy of percutaneous catheter drainage in 50 patients. Tex Heart Inst J 31(4):398–403PubMed
18.
Zurück zum Zitat Koga S, Ikeda S, Urata J et al (2008) Primary high-grade myofibroblastic sarcoma arising from the pericardium. Circ J 72(2):337–339PubMedCrossRef Koga S, Ikeda S, Urata J et al (2008) Primary high-grade myofibroblastic sarcoma arising from the pericardium. Circ J 72(2):337–339PubMedCrossRef
19.
Zurück zum Zitat Holmes DR Jr, Nishimura R, Fountain R, Turi ZG (2009) Iatrogenic pericardial effusion and tamponade in the percutaneous intracardiac intervention era. JACC Cardiovasc Interv 2(8):705–717PubMedCrossRef Holmes DR Jr, Nishimura R, Fountain R, Turi ZG (2009) Iatrogenic pericardial effusion and tamponade in the percutaneous intracardiac intervention era. JACC Cardiovasc Interv 2(8):705–717PubMedCrossRef
20.
Zurück zum Zitat Cappato R, Calkins H, Chen SA et al (2010) Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 3(1):32–38PubMedCrossRef Cappato R, Calkins H, Chen SA et al (2010) Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 3(1):32–38PubMedCrossRef
21.
Zurück zum Zitat Cappato R, Calkins H, Chen SA et al (2005) Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 111(9):1100–1105PubMedCrossRef Cappato R, Calkins H, Chen SA et al (2005) Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 111(9):1100–1105PubMedCrossRef
22.
Zurück zum Zitat Deneke T, Mügge A (2009) Treatment of cardiac tamponade during electrophysiology procedures: do electrophysiologists need more than drainage? J Cardiovasc Electrophysiol 20(3):284–286PubMedCrossRef Deneke T, Mügge A (2009) Treatment of cardiac tamponade during electrophysiology procedures: do electrophysiologists need more than drainage? J Cardiovasc Electrophysiol 20(3):284–286PubMedCrossRef
23.
Zurück zum Zitat Seca L, Costa M, Quintal N, Marques AM (2008) Percutaneous mitral valvuloplasty complicated by cardiac tamponade in a pregnant patient. Arq Bras Cardiol 91(5):e45–e47PubMedCrossRef Seca L, Costa M, Quintal N, Marques AM (2008) Percutaneous mitral valvuloplasty complicated by cardiac tamponade in a pregnant patient. Arq Bras Cardiol 91(5):e45–e47PubMedCrossRef
24.
Zurück zum Zitat Chen SW, Liu SW, Lin JX (2008) Incidence, risk factors and management of pericardial effusion post radiofrequency catheter ablation in patients with atrial fibrillations. Zhonghua Xin Xue Guan Bing Za Zhi 36(9):801–806 [Article in Chinese]PubMed Chen SW, Liu SW, Lin JX (2008) Incidence, risk factors and management of pericardial effusion post radiofrequency catheter ablation in patients with atrial fibrillations. Zhonghua Xin Xue Guan Bing Za Zhi 36(9):801–806 [Article in Chinese]PubMed
25.
Zurück zum Zitat Ma CS, Dong JZ, Liu X et al (2003) Risk factors and causes of acute cardiac tamponade complicating radiofrequency catheter ablation for tachyarrhythmias. Zhonghua Xin Lv Shi Chang Xue Za Zhi 13(5):321–323. [Article in Chinese] Ma CS, Dong JZ, Liu X et al (2003) Risk factors and causes of acute cardiac tamponade complicating radiofrequency catheter ablation for tachyarrhythmias. Zhonghua Xin Lv Shi Chang Xue Za Zhi 13(5):321–323. [Article in Chinese]
26.
Zurück zum Zitat Lau EW, Shannon HJ, McKavanagh P (2008) Delayed cardiac perforation by defibrillator lead placed in the right ventricular outflow tract resulting in massive pericardial effusion. Pacing Clin Electrophysiol 31(12):1646–1649PubMedCrossRef Lau EW, Shannon HJ, McKavanagh P (2008) Delayed cardiac perforation by defibrillator lead placed in the right ventricular outflow tract resulting in massive pericardial effusion. Pacing Clin Electrophysiol 31(12):1646–1649PubMedCrossRef
27.
Zurück zum Zitat Cheng TO (2003) Hemopericardium complicating acute myocardial infarction. Tex Heart Inst J 30(4):345–346PubMed Cheng TO (2003) Hemopericardium complicating acute myocardial infarction. Tex Heart Inst J 30(4):345–346PubMed
28.
Zurück zum Zitat Biedrzycki O, Baithun S (2006) Seasonal variation in mortality from myocardial infarction and haemopericardium. A postmortem study. J Clin Pathol 59(1):64–66PubMedCrossRef Biedrzycki O, Baithun S (2006) Seasonal variation in mortality from myocardial infarction and haemopericardium. A postmortem study. J Clin Pathol 59(1):64–66PubMedCrossRef
Metadaten
Titel
Causes of moderate to large pericardial effusion requiring pericardiocentesis in 140 Han Chinese patients
verfasst von
W. Ma
J. Liu
Y. Zeng
S. Chen
Y. Zheng
S. Ye
L. Lan
Q. Liu
H.-J. Weig
Q. Liu, MD, PhD
Publikationsdatum
01.03.2012
Verlag
Urban and Vogel
Erschienen in
Herz / Ausgabe 2/2012
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-011-3428-5

Weitere Artikel der Ausgabe 2/2012

Herz 2/2012 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.